|
Summary Information: Xencor Inc. Common Stock NASDAQ:XNCR |
  admin@troach.net |
Our Main Pages Stocks.TRoach.Net TRoach.Org TRoach.Net |
_Description: Xencor is a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases. Currently, 20 candidates engineered with Xencor's XmAb® technology are in clinical development internally and with partners. Xencor's XmAb antibody engineering technology enables small changes to the structure of proteins resulting in new mechanisms of therapeutic action.
__The following are links to various summary and news pages for __Xencor Inc. Common Stock [ XNCR ]. __Note: Some Links might not have information for the company. |
|